168 related articles for article (PubMed ID: 16738854)
21. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
Morlock R; Goodwin B; Gomez Rey G; Eaddy M
Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
[TBL] [Abstract][Full Text] [Related]
22. Systematic review and meta-analysis on management of acute urinary retention.
Yoon PD; Chalasani V; Woo HH
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):297-302. PubMed ID: 26195469
[TBL] [Abstract][Full Text] [Related]
23. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
[TBL] [Abstract][Full Text] [Related]
24. The incidence of acute urinary retention secondary to BPH is increasing among California men.
Groves HK; Chang D; Palazzi K; Cohen S; Parsons JK
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):260-5. PubMed ID: 23648398
[TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study.
Pandit RK; Agrawal CS; Chalise PR; Sapkota G
Kathmandu Univ Med J (KUMJ); 2008; 6(24):448-52. PubMed ID: 19483424
[TBL] [Abstract][Full Text] [Related]
26. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia.
Ho CC; Ngoo KS; Hamzaini AH; Rizal AM; Zulkifli MZ
Clin Ter; 2014; 165(2):75-81. PubMed ID: 24770808
[TBL] [Abstract][Full Text] [Related]
27. Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management.
Muruganandham K; Dubey D; Kapoor R
Indian J Urol; 2007 Oct; 23(4):347-53. PubMed ID: 19718286
[TBL] [Abstract][Full Text] [Related]
28. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery.
Boyle P; Roehrborn C; Harkaway R; Logie J; de la Rosette J; Emberton M
Eur Urol; 2004 May; 45(5):620-6; discussion 626-7. PubMed ID: 15082205
[TBL] [Abstract][Full Text] [Related]
29. [Alpha-adrenergic blockers as a support in the treatment of acute urinary retention].
Altarac S
Lijec Vjesn; 2006; 128(7-8):233-7. PubMed ID: 17087140
[TBL] [Abstract][Full Text] [Related]
30. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
Roehrborn CG
BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
[TBL] [Abstract][Full Text] [Related]
31. Does acute urinary retention respond to alpha-blockers alone?
McNeill SA
Eur Urol; 2001 Mar; 39 Suppl 6():7-12. PubMed ID: 11306895
[TBL] [Abstract][Full Text] [Related]
32. [Doxazosin in the gastrointestinal therapeutic system (GITS) formulation and trial without catheter after acute urinary retention due to BPH. Dose increase action on recovery effect].
Lorente Garín JA; Cañis Sánchez D; Arango Toro O; Bielsa Gali O; Cortadellas Angel R; Gelabert Mas A
Actas Urol Esp; 2004 Jan; 28(1):32-7. PubMed ID: 15046478
[TBL] [Abstract][Full Text] [Related]
33. Low incidence of acute urinary retention in the general male population: the triumph project.
Verhamme KM; Dieleman JP; van Wijk MA; Bosch JL; Stricker BH; Sturkenboom MC
Eur Urol; 2005 Apr; 47(4):494-8. PubMed ID: 15774248
[TBL] [Abstract][Full Text] [Related]
34. Acute urinary retention: developing an A&E management pathway.
Anderson B; Khadra A
Br J Nurs; 2006 Apr 27-May 10; 15(8):434-8. PubMed ID: 16723949
[TBL] [Abstract][Full Text] [Related]
35. Holmium laser prostatic resection for patients presenting with acute urinary retention.
Anderson CB; Helfand BT; McVary KT
BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443
[TBL] [Abstract][Full Text] [Related]
36. Long-term aspects of medical treatment of BPH.
Schulman CC
Eur Urol; 2001; 40 Suppl 3():8-12. PubMed ID: 11786671
[TBL] [Abstract][Full Text] [Related]
37. The possible association between serum interleukin 8 and acute urinary retention in Chinese patients with benign prostatic hyperplasia.
Wu D; Tang HX; Wu Y; Qian SB; Xu D; Qi J
Andrologia; 2020 Dec; 52(11):e13763. PubMed ID: 32829482
[TBL] [Abstract][Full Text] [Related]
38. [The incidence of acute urinary retention as an indicator of the quality of care for patients with benign prostatic hyperplasia].
Apolikhin OI; Sivkov AV; Yanenko EK; Katibov MI; Zolotukhin OV; Shaderkin IA; Prosyannikov MY; Voitko DA; Tsoi AA; Galiev NA; Kastrikin YV
Urologiia; 2016 Apr; (2):43-48. PubMed ID: 28247660
[TBL] [Abstract][Full Text] [Related]
39. Urodynamic impact of acute urinary retention in patients with benign prostatic hyperplasia: a 2-year follow-up after transurethral resection of the prostate.
Wagenlehner FM; Bescherer K; Wagenlehner C; Zellner M; Weidner W; Naber KG
Urol Int; 2011; 86(1):73-9. PubMed ID: 20689259
[TBL] [Abstract][Full Text] [Related]
40. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
Bao QB; He GH; Liu GY; Zhang CG; Yang C
Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
